

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | sarcomere organization (GO:0045214) | 7.76634757 |
| 2 | actin-myosin filament sliding (GO:0033275) | 7.51116196 |
| 3 | muscle filament sliding (GO:0030049) | 7.51116196 |
| 4 | regulation of skeletal muscle contraction (GO:0014819) | 7.29991504 |
| 5 | myofibril assembly (GO:0030239) | 7.00033320 |
| 6 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 6.69916909 |
| 7 | cardiac myofibril assembly (GO:0055003) | 6.67814228 |
| 8 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 6.66800983 |
| 9 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 6.59339759 |
| 10 | actin-mediated cell contraction (GO:0070252) | 6.36002758 |
| 11 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 6.35297917 |
| 12 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 6.12636212 |
| 13 | skeletal muscle fiber development (GO:0048741) | 5.90126134 |
| 14 | regulation of actin filament-based movement (GO:1903115) | 5.87993312 |
| 15 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 5.85822258 |
| 16 | cardiac muscle contraction (GO:0060048) | 5.72321428 |
| 17 | regulation of cell communication by electrical coupling (GO:0010649) | 5.69791364 |
| 18 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 5.59375829 |
| 19 | regulation of relaxation of muscle (GO:1901077) | 5.54150878 |
| 20 | plasma membrane repair (GO:0001778) | 5.47115083 |
| 21 | NADH metabolic process (GO:0006734) | 5.43792503 |
| 22 | striated muscle contraction (GO:0006941) | 5.38568385 |
| 23 | skeletal muscle contraction (GO:0003009) | 5.36777567 |
| 24 | myotube cell development (GO:0014904) | 5.33636292 |
| 25 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 5.21331057 |
| 26 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 5.16920720 |
| 27 | adult heart development (GO:0007512) | 5.05015716 |
| 28 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 5.03871772 |
| 29 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 5.01379405 |
| 30 | actomyosin structure organization (GO:0031032) | 4.96172614 |
| 31 | cardiac muscle cell development (GO:0055013) | 4.87574871 |
| 32 | regulation of striated muscle contraction (GO:0006942) | 4.78256703 |
| 33 | glucan catabolic process (GO:0009251) | 4.76923688 |
| 34 | creatine metabolic process (GO:0006600) | 4.72686310 |
| 35 | actin filament-based movement (GO:0030048) | 4.72530885 |
| 36 | muscle fiber development (GO:0048747) | 4.71147799 |
| 37 | glucan biosynthetic process (GO:0009250) | 4.70788753 |
| 38 | glycogen biosynthetic process (GO:0005978) | 4.70788753 |
| 39 | cardiac muscle tissue morphogenesis (GO:0055008) | 4.66629198 |
| 40 | heart process (GO:0003015) | 4.66564705 |
| 41 | heart contraction (GO:0060047) | 4.66564705 |
| 42 | ventricular cardiac muscle cell action potential (GO:0086005) | 4.59957648 |
| 43 | cardiac cell development (GO:0055006) | 4.59434202 |
| 44 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 4.49231690 |
| 45 | negative regulation of protein localization to cell surface (GO:2000009) | 4.49065119 |
| 46 | cellular polysaccharide catabolic process (GO:0044247) | 4.46737130 |
| 47 | regulation of sarcomere organization (GO:0060297) | 4.42172692 |
| 48 | skeletal muscle tissue development (GO:0007519) | 4.40033831 |
| 49 | skeletal muscle adaptation (GO:0043501) | 4.37164398 |
| 50 | carnitine shuttle (GO:0006853) | 4.33106611 |
| 51 | regulation of membrane repolarization (GO:0060306) | 4.30796137 |
| 52 | muscle tissue morphogenesis (GO:0060415) | 4.26460161 |
| 53 | respiratory electron transport chain (GO:0022904) | 4.26386483 |
| 54 | 2-oxoglutarate metabolic process (GO:0006103) | 4.24558604 |
| 55 | ventricular cardiac muscle tissue morphogenesis (GO:0055010) | 4.23207921 |
| 56 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 4.22018540 |
| 57 | tricarboxylic acid cycle (GO:0006099) | 4.21080898 |
| 58 | cardiac muscle hypertrophy (GO:0003300) | 4.16917944 |
| 59 | electron transport chain (GO:0022900) | 4.13101082 |
| 60 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 4.12489593 |
| 61 | response to inactivity (GO:0014854) | 4.09616951 |
| 62 | muscle cell cellular homeostasis (GO:0046716) | 4.08748243 |
| 63 | striated muscle hypertrophy (GO:0014897) | 4.06848207 |
| 64 | regulation of cardiac muscle cell contraction (GO:0086004) | 4.06259003 |
| 65 | positive regulation of myotube differentiation (GO:0010831) | 4.05169136 |
| 66 | polysaccharide catabolic process (GO:0000272) | 4.01424939 |
| 67 | skeletal muscle tissue regeneration (GO:0043403) | 3.95262936 |
| 68 | ATP synthesis coupled proton transport (GO:0015986) | 3.93544535 |
| 69 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 3.93544535 |
| 70 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 3.91995144 |
| 71 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 3.87693706 |
| 72 | regulation of cardiac muscle contraction (GO:0055117) | 3.87584838 |
| 73 | cardiac muscle adaptation (GO:0014887) | 3.83979934 |
| 74 | cardiac muscle hypertrophy in response to stress (GO:0014898) | 3.83979934 |
| 75 | muscle hypertrophy in response to stress (GO:0003299) | 3.83979934 |
| 76 | muscle contraction (GO:0006936) | 3.78654951 |
| 77 | response to muscle activity (GO:0014850) | 3.76381883 |
| 78 | glycogen metabolic process (GO:0005977) | 3.74140297 |
| 79 | relaxation of cardiac muscle (GO:0055119) | 3.70817817 |
| 80 | muscle organ morphogenesis (GO:0048644) | 3.70764284 |
| 81 | muscle organ development (GO:0007517) | 3.70250674 |
| 82 | muscle structure development (GO:0061061) | 3.69497255 |
| 83 | heart trabecula formation (GO:0060347) | 3.69359388 |
| 84 | gluconeogenesis (GO:0006094) | 3.68176599 |
| 85 | cellular glucan metabolic process (GO:0006073) | 3.66522265 |
| 86 | glucan metabolic process (GO:0044042) | 3.66522265 |
| 87 | muscle adaptation (GO:0043500) | 3.65847357 |
| 88 | negative regulation of calcium ion transmembrane transporter activity (GO:1901020) | 3.64745285 |
| 89 | negative regulation of calcium ion transmembrane transport (GO:1903170) | 3.64745285 |
| 90 | fatty acid transmembrane transport (GO:1902001) | 3.61381303 |
| 91 | regulation of the force of heart contraction (GO:0002026) | 3.61370865 |
| 92 | negative regulation of muscle hypertrophy (GO:0014741) | 3.59616980 |
| 93 | muscle cell fate commitment (GO:0042693) | 3.59174470 |
| 94 | fructose metabolic process (GO:0006000) | 3.58242835 |
| 95 | positive regulation of cation channel activity (GO:2001259) | 3.55975559 |
| 96 | muscle hypertrophy (GO:0014896) | 3.54535773 |
| 97 | regulation of coenzyme metabolic process (GO:0051196) | 3.54172478 |
| 98 | regulation of cofactor metabolic process (GO:0051193) | 3.54172478 |
| 99 | muscle system process (GO:0003012) | 3.52597400 |
| 100 | response to activity (GO:0014823) | 3.52016055 |
| 101 | regulation of sequestering of triglyceride (GO:0010889) | 3.51985813 |
| 102 | positive regulation of heart rate (GO:0010460) | 3.51638912 |
| 103 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.51066666 |
| 104 | cell communication involved in cardiac conduction (GO:0086065) | 3.48404040 |
| 105 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 3.47724378 |
| 106 | regulation of calcium ion transmembrane transport (GO:1903169) | 3.47724378 |
| 107 | gonadal mesoderm development (GO:0007506) | 3.45259548 |
| 108 | cardiac muscle cell action potential (GO:0086001) | 3.43086534 |
| 109 | regulation of ATP catabolic process (GO:1903289) | 3.40495880 |
| 110 | regulation of ATPase activity (GO:0043462) | 3.40495880 |
| 111 | regulation of heart rate (GO:0002027) | 3.40128743 |
| 112 | cardiac muscle cell action potential involved in contraction (GO:0086002) | 3.38097095 |
| 113 | striated muscle adaptation (GO:0014888) | 3.37017485 |
| 114 | muscle cell development (GO:0055001) | 3.36937999 |
| 115 | regulation of muscle system process (GO:0090257) | 3.35706824 |
| 116 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 3.34095141 |
| 117 | detection of calcium ion (GO:0005513) | 3.33350250 |
| 118 | striated muscle atrophy (GO:0014891) | 3.32891185 |
| 119 | relaxation of muscle (GO:0090075) | 3.29917185 |
| 120 | hexose biosynthetic process (GO:0019319) | 3.29511302 |
| 121 | regulation of muscle contraction (GO:0006937) | 3.27414023 |
| 122 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 3.27375466 |
| 123 | negative regulation of cardiac muscle hypertrophy (GO:0010614) | 3.26591234 |
| 124 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.23509464 |
| 125 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 3.21825541 |
| 126 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 3.19828367 |
| 127 | regulation of heart contraction (GO:0008016) | 3.19095687 |
| 128 | adrenergic receptor signaling pathway (GO:0071875) | 3.16705994 |
| 129 | ubiquinone biosynthetic process (GO:0006744) | 3.14749756 |
| 130 | quinone biosynthetic process (GO:1901663) | 3.14749756 |
| 131 | glycogen catabolic process (GO:0005980) | 3.13067210 |
| 132 | striated muscle cell development (GO:0055002) | 3.12939123 |
| 133 | muscle atrophy (GO:0014889) | 3.12878435 |
| 134 | cytidine deamination (GO:0009972) | 3.08666963 |
| 135 | cytidine metabolic process (GO:0046087) | 3.08666963 |
| 136 | cytidine catabolic process (GO:0006216) | 3.08666963 |
| 137 | carnitine transmembrane transport (GO:1902603) | 3.08656223 |
| 138 | cardiac conduction (GO:0061337) | 3.02308182 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 4.47097605 |
| 2 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 3.00496486 |
| 3 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.75546081 |
| 4 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 2.57091138 |
| 5 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.41978599 |
| 6 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.35225215 |
| 7 | VDR_22108803_ChIP-Seq_LS180_Human | 2.28317574 |
| 8 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.24699669 |
| 9 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.24328235 |
| 10 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 2.20905294 |
| 11 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.20730175 |
| 12 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.19992451 |
| 13 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 2.19395195 |
| 14 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.17362931 |
| 15 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.12180053 |
| 16 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.06200712 |
| 17 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 2.04559070 |
| 18 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 2.04559070 |
| 19 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 2.04295975 |
| 20 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.04239083 |
| 21 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.00091460 |
| 22 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.97832374 |
| 23 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.93864030 |
| 24 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.92669590 |
| 25 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.92303950 |
| 26 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.92303950 |
| 27 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.88830908 |
| 28 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.80641954 |
| 29 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.77926376 |
| 30 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.75761138 |
| 31 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.74237725 |
| 32 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.71919938 |
| 33 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.67322812 |
| 34 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.66145382 |
| 35 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.61778037 |
| 36 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.61091317 |
| 37 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.60114309 |
| 38 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 1.58048253 |
| 39 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.53506967 |
| 40 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.50104708 |
| 41 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.49956893 |
| 42 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.44988120 |
| 43 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.44329991 |
| 44 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.42365600 |
| 45 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.41042141 |
| 46 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.40241051 |
| 47 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.38448702 |
| 48 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.35672438 |
| 49 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.32647323 |
| 50 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.32388063 |
| 51 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.32245853 |
| 52 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.28171572 |
| 53 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.25550472 |
| 54 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.23403863 |
| 55 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.23345888 |
| 56 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 1.22654323 |
| 57 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.22305577 |
| 58 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.21290757 |
| 59 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.21105819 |
| 60 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.20653390 |
| 61 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.19431144 |
| 62 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.19222393 |
| 63 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.18722164 |
| 64 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.18541656 |
| 65 | * CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.18433818 |
| 66 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 1.17304161 |
| 67 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.16829040 |
| 68 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.16127297 |
| 69 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.15229522 |
| 70 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.13868286 |
| 71 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.13212814 |
| 72 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.12515072 |
| 73 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.11382953 |
| 74 | SPI1_20517297_ChIP-Seq_HL60_Human | 1.11343077 |
| 75 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.11314902 |
| 76 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.10799679 |
| 77 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.10489300 |
| 78 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.09469128 |
| 79 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.08893973 |
| 80 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 1.08792081 |
| 81 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.06911816 |
| 82 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.04920256 |
| 83 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.03911186 |
| 84 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.03902514 |
| 85 | OCT4_20526341_ChIP-Seq_ESCs_Human | 1.03795440 |
| 86 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.03563480 |
| 87 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 1.03380460 |
| 88 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 1.03264608 |
| 89 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.02109224 |
| 90 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.01903469 |
| 91 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.01795548 |
| 92 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.01621543 |
| 93 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.00860964 |
| 94 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.00818965 |
| 95 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.00737064 |
| 96 | SA1_27219007_Chip-Seq_Bcells_Human | 1.00121919 |
| 97 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.99784809 |
| 98 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.98634312 |
| 99 | CTCF_21964334_Chip-Seq_Bcells_Human | 0.97847681 |
| 100 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.97551340 |
| 101 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.97451772 |
| 102 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.96211890 |
| 103 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.95926706 |
| 104 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.95041060 |
| 105 | IGF1R_20145208_ChIP-Seq_DFB_Human | 0.94926330 |
| 106 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.94890664 |
| 107 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.93968622 |
| 108 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.93556109 |
| 109 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.93463092 |
| 110 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.93123388 |
| 111 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.92238170 |
| 112 | P300_19829295_ChIP-Seq_ESCs_Human | 0.92115103 |
| 113 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.92094731 |
| 114 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.92032133 |
| 115 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.91988206 |
| 116 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.91444151 |
| 117 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.91322065 |
| 118 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 0.90151554 |
| 119 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.89475850 |
| 120 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 0.88433618 |
| 121 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.88173832 |
| 122 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.87259908 |
| 123 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.87160986 |
| 124 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.86485477 |
| 125 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.86336379 |
| 126 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 0.85837817 |
| 127 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 0.85656240 |
| 128 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 0.85629384 |
| 129 | PCGF4_22325352_ChIP-Seq_293T-Rex_Human | 0.85402672 |
| 130 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 0.85178511 |
| 131 | TBL1_22424771_ChIP-Seq_293T_Human | 0.84770899 |
| 132 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.84720643 |
| 133 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 0.84578247 |
| 134 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.83781999 |
| 135 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.83438518 |
| 136 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.82683605 |
| 137 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.82645334 |
| 138 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.82304694 |
| 139 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 0.82189115 |
| 140 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.82021657 |
| 141 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.80993012 |
| 142 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.80942758 |
| 143 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.80942758 |
| 144 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.80550263 |
| 145 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.80535280 |
| 146 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.80210945 |
| 147 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.79672812 |
| 148 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.79637400 |
| 149 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.78959945 |
| 150 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.78719027 |
| 151 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.76070853 |
| 152 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.75544629 |
| 153 | PRDM14_21183938_ChIP-Seq_MESCs_Mouse | 0.74098688 |
| 154 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.74002130 |
| 155 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.73861081 |
| 156 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.73802386 |
| 157 | DPY_21335234_ChIP-Seq_ESCs_Mouse | 0.73469422 |
| 158 | GATA3_21867929_ChIP-Seq_CD8_Mouse | 0.73323871 |
| 159 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 0.71436415 |
| 160 | TP53_23651856_ChIP-Seq_MEFs_Mouse | 0.71206387 |
| 161 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.70921228 |
| 162 | P68_20966046_ChIP-Seq_HELA_Human | 0.68886933 |
| 163 | * SMC4_20622854_ChIP-Seq_HELA_Human | 0.66112663 |
| 164 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.65124708 |
| 165 | OCT4_19829295_ChIP-Seq_ESCs_Human | 0.63955933 |
| 166 | GATA6_21074721_ChIP-Seq_CACO-2_Human | 0.62924145 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002837_dystrophic_cardiac_calcinosis | 6.24537236 |
| 2 | MP0003646_muscle_fatigue | 6.06015537 |
| 3 | MP0000751_myopathy | 5.26914426 |
| 4 | MP0000749_muscle_degeneration | 4.55149051 |
| 5 | MP0004084_abnormal_cardiac_muscle | 4.37752680 |
| 6 | MP0004036_abnormal_muscle_relaxation | 4.15129095 |
| 7 | MP0004215_abnormal_myocardial_fiber | 4.08023743 |
| 8 | MP0004145_abnormal_muscle_electrophysio | 4.05449092 |
| 9 | MP0005330_cardiomyopathy | 3.32414590 |
| 10 | MP0005620_abnormal_muscle_contractility | 2.90303650 |
| 11 | MP0002106_abnormal_muscle_physiology | 2.88860683 |
| 12 | MP0004087_abnormal_muscle_fiber | 2.87291670 |
| 13 | MP0003137_abnormal_impulse_conducting | 2.75212892 |
| 14 | MP0002972_abnormal_cardiac_muscle | 2.73148428 |
| 15 | MP0000750_abnormal_muscle_regeneration | 2.68648933 |
| 16 | MP0004130_abnormal_muscle_cell | 2.50161602 |
| 17 | MP0000759_abnormal_skeletal_muscle | 2.41389068 |
| 18 | MP0005369_muscle_phenotype | 2.38579720 |
| 19 | MP0004484_altered_response_of | 2.33341580 |
| 20 | MP0000747_muscle_weakness | 2.32978141 |
| 21 | MP0003828_pulmonary_edema | 2.24529334 |
| 22 | MP0002269_muscular_atrophy | 2.22530583 |
| 23 | MP0008775_abnormal_heart_ventricle | 2.16569852 |
| 24 | MP0001544_abnormal_cardiovascular_syste | 2.07252504 |
| 25 | MP0005385_cardiovascular_system_phenoty | 2.07252504 |
| 26 | MP0010630_abnormal_cardiac_muscle | 1.96797629 |
| 27 | MP0006138_congestive_heart_failure | 1.94862748 |
| 28 | MP0004085_abnormal_heartbeat | 1.86349302 |
| 29 | MP0002332_abnormal_exercise_endurance | 1.69155388 |
| 30 | MP0003950_abnormal_plasma_membrane | 1.67828308 |
| 31 | MP0004233_abnormal_muscle_weight | 1.56931403 |
| 32 | MP0006036_abnormal_mitochondrial_physio | 1.56259106 |
| 33 | MP0005666_abnormal_adipose_tissue | 1.49253727 |
| 34 | MP0003221_abnormal_cardiomyocyte_apopto | 1.44208333 |
| 35 | MP0002127_abnormal_cardiovascular_syste | 1.35294140 |
| 36 | MP0003136_yellow_coat_color | 1.31037309 |
| 37 | MP0005451_abnormal_body_composition | 1.28311159 |
| 38 | MP0005670_abnormal_white_adipose | 1.27653450 |
| 39 | MP0004510_myositis | 1.18851949 |
| 40 | MP0002108_abnormal_muscle_morphology | 1.11134150 |
| 41 | MP0004185_abnormal_adipocyte_glucose | 1.10627587 |
| 42 | MP0001661_extended_life_span | 1.07951759 |
| 43 | MP0005165_increased_susceptibility_to | 1.07902068 |
| 44 | MP0002234_abnormal_pharynx_morphology | 1.04755337 |
| 45 | MP0000343_altered_response_to | 0.97976414 |
| 46 | MP0005375_adipose_tissue_phenotype | 0.97499221 |
| 47 | MP0004043_abnormal_pH_regulation | 0.94736549 |
| 48 | MP0005171_absent_coat_pigmentation | 0.85478615 |
| 49 | MP0000230_abnormal_systemic_arterial | 0.82085896 |
| 50 | MP0006035_abnormal_mitochondrial_morpho | 0.81204398 |
| 51 | MP0003941_abnormal_skin_development | 0.79422142 |
| 52 | MP0000733_abnormal_muscle_development | 0.78538108 |
| 53 | MP0000266_abnormal_heart_morphology | 0.77128938 |
| 54 | MP0004381_abnormal_hair_follicle | 0.76480951 |
| 55 | MP0003045_fibrosis | 0.66016624 |
| 56 | MP0000762_abnormal_tongue_morphology | 0.64264579 |
| 57 | MP0002971_abnormal_brown_adipose | 0.62809189 |
| 58 | MP0001485_abnormal_pinna_reflex | 0.60918168 |
| 59 | MP0004270_analgesia | 0.60610667 |
| 60 | MP0009780_abnormal_chondrocyte_physiolo | 0.59801751 |
| 61 | MP0002638_abnormal_pupillary_reflex | 0.59222626 |
| 62 | MP0005409_darkened_coat_color | 0.58457245 |
| 63 | MP0005266_abnormal_metabolism | 0.58408659 |
| 64 | MP0000372_irregular_coat_pigmentation | 0.58285318 |
| 65 | MP0002822_catalepsy | 0.56566862 |
| 66 | MP0001879_abnormal_lymphatic_vessel | 0.56477171 |
| 67 | MP0005377_hearing/vestibular/ear_phenot | 0.55947705 |
| 68 | MP0003878_abnormal_ear_physiology | 0.55947705 |
| 69 | MP0000920_abnormal_myelination | 0.54672863 |
| 70 | MP0009250_abnormal_appendicular_skeleto | 0.53612184 |
| 71 | MP0001727_abnormal_embryo_implantation | 0.52883443 |
| 72 | MP0003656_abnormal_erythrocyte_physiolo | 0.52853243 |
| 73 | MP0006072_abnormal_retinal_apoptosis | 0.52156348 |
| 74 | MP0006292_abnormal_olfactory_placode | 0.51377517 |
| 75 | MP0000579_abnormal_nail_morphology | 0.50246483 |
| 76 | MP0001529_abnormal_vocalization | 0.48096421 |
| 77 | MP0002128_abnormal_blood_circulation | 0.47457253 |
| 78 | MP0005623_abnormal_meninges_morphology | 0.45819776 |
| 79 | MP0003567_abnormal_fetal_cardiomyocyte | 0.44820151 |
| 80 | MP0001299_abnormal_eye_distance/ | 0.44587427 |
| 81 | MP0004134_abnormal_chest_morphology | 0.43425938 |
| 82 | MP0008569_lethality_at_weaning | 0.42825773 |
| 83 | MP0004142_abnormal_muscle_tone | 0.41958733 |
| 84 | MP0003279_aneurysm | 0.41790006 |
| 85 | MP0005595_abnormal_vascular_smooth | 0.40493771 |
| 86 | MP0002272_abnormal_nervous_system | 0.40270327 |
| 87 | MP0003880_abnormal_central_pattern | 0.40243870 |
| 88 | MP0010368_abnormal_lymphatic_system | 0.39280642 |
| 89 | MP0006276_abnormal_autonomic_nervous | 0.38415447 |
| 90 | MP0001486_abnormal_startle_reflex | 0.38357069 |
| 91 | MP0002078_abnormal_glucose_homeostasis | 0.38076173 |
| 92 | MP0003879_abnormal_hair_cell | 0.37404551 |
| 93 | MP0000003_abnormal_adipose_tissue | 0.37089371 |
| 94 | MP0000026_abnormal_inner_ear | 0.37061292 |
| 95 | MP0000566_synostosis | 0.36896755 |
| 96 | MP0004147_increased_porphyrin_level | 0.36706691 |
| 97 | MP0003948_abnormal_gas_homeostasis | 0.36628632 |
| 98 | MP0001905_abnormal_dopamine_level | 0.36405959 |
| 99 | MP0001346_abnormal_lacrimal_gland | 0.35870528 |
| 100 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.35249457 |
| 101 | MP0002102_abnormal_ear_morphology | 0.35196123 |
| 102 | MP0005376_homeostasis/metabolism_phenot | 0.35047713 |
| 103 | MP0004742_abnormal_vestibular_system | 0.34610460 |
| 104 | MP0002067_abnormal_sensory_capabilities | 0.34100165 |
| 105 | MP0005334_abnormal_fat_pad | 0.33954009 |
| 106 | MP0005535_abnormal_body_temperature | 0.33917444 |
| 107 | MP0005551_abnormal_eye_electrophysiolog | 0.33395391 |
| 108 | MP0009672_abnormal_birth_weight | 0.32587845 |
| 109 | MP0000013_abnormal_adipose_tissue | 0.31296837 |
| 110 | MP0005423_abnormal_somatic_nervous | 0.31189061 |
| 111 | MP0002752_abnormal_somatic_nervous | 0.30910475 |
| 112 | MP0005166_decreased_susceptibility_to | 0.30346494 |
| 113 | MP0002249_abnormal_larynx_morphology | 0.30029454 |
| 114 | MP0004924_abnormal_behavior | 0.29401854 |
| 115 | MP0005452_abnormal_adipose_tissue | 0.28411488 |
| 116 | MP0002114_abnormal_axial_skeleton | 0.26516684 |
| 117 | MP0005332_abnormal_amino_acid | 0.25780125 |
| 118 | MP0005319_abnormal_enzyme/_coenzyme | 0.25655437 |
| 119 | MP0010030_abnormal_orbit_morphology | 0.23595559 |
| 120 | MP0005167_abnormal_blood-brain_barrier | 0.23081401 |
| 121 | MP0005083_abnormal_biliary_tract | 0.22579197 |
| 122 | MP0002896_abnormal_bone_mineralization | 0.20976422 |
| 123 | MP0001943_abnormal_respiration | 0.18791497 |
| 124 | MP0002066_abnormal_motor_capabilities/c | 0.18155557 |
| 125 | MP0005187_abnormal_penis_morphology | 0.17724311 |
| 126 | MP0003959_abnormal_lean_body | 0.16195852 |
| 127 | MP0009115_abnormal_fat_cell | 0.14843946 |
| 128 | MP0008874_decreased_physiological_sensi | 0.13909370 |
| 129 | MP0009840_abnormal_foam_cell | 0.13812645 |
| 130 | MP0005386_behavior/neurological_phenoty | 0.13592000 |
| 131 | MP0002734_abnormal_mechanical_nocicepti | 0.10988476 |
| 132 | MP0003705_abnormal_hypodermis_morpholog | 0.10269090 |
| 133 | MP0003806_abnormal_nucleotide_metabolis | 0.09938516 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Muscle hypertrophy of the lower extremities (HP:0008968) | 7.25167637 |
| 2 | Exercise-induced myalgia (HP:0003738) | 7.21957806 |
| 3 | Calf muscle hypertrophy (HP:0008981) | 7.15799220 |
| 4 | Sudden death (HP:0001699) | 6.74159670 |
| 5 | Exercise-induced muscle cramps (HP:0003710) | 6.64174553 |
| 6 | Ventricular tachycardia (HP:0004756) | 6.02169012 |
| 7 | Muscle fiber splitting (HP:0003555) | 5.95120014 |
| 8 | Abnormality of the calf musculature (HP:0001430) | 5.41583363 |
| 9 | Atrial fibrillation (HP:0005110) | 5.12177356 |
| 10 | Hyporeflexia of lower limbs (HP:0002600) | 5.05441173 |
| 11 | Muscle fiber inclusion bodies (HP:0100299) | 4.93234709 |
| 12 | Myoglobinuria (HP:0002913) | 4.87924285 |
| 13 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 4.82313048 |
| 14 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 4.75701004 |
| 15 | Primary atrial arrhythmia (HP:0001692) | 4.75483571 |
| 16 | Abnormality of the left ventricular outflow tract (HP:0011103) | 4.58721849 |
| 17 | Subaortic stenosis (HP:0001682) | 4.58721849 |
| 18 | Supraventricular tachycardia (HP:0004755) | 4.57270705 |
| 19 | Ulnar deviation of the wrist (HP:0003049) | 4.55921378 |
| 20 | EMG: myopathic abnormalities (HP:0003458) | 4.48205275 |
| 21 | Supraventricular arrhythmia (HP:0005115) | 4.44427557 |
| 22 | Lipoatrophy (HP:0100578) | 4.37426419 |
| 23 | Difficulty running (HP:0009046) | 4.27727560 |
| 24 | Nemaline bodies (HP:0003798) | 4.12139229 |
| 25 | Calcaneovalgus deformity (HP:0001848) | 3.99259616 |
| 26 | Syncope (HP:0001279) | 3.95383458 |
| 27 | Dilated cardiomyopathy (HP:0001644) | 3.85382668 |
| 28 | Prolonged QT interval (HP:0001657) | 3.78129246 |
| 29 | Rhabdomyolysis (HP:0003201) | 3.69765611 |
| 30 | Myotonia (HP:0002486) | 3.69056995 |
| 31 | Bundle branch block (HP:0011710) | 3.66538849 |
| 32 | Right ventricular cardiomyopathy (HP:0011663) | 3.63810317 |
| 33 | Increased connective tissue (HP:0009025) | 3.61697539 |
| 34 | Asymmetric septal hypertrophy (HP:0001670) | 3.58114298 |
| 35 | Deformed tarsal bones (HP:0008119) | 3.52814922 |
| 36 | Type 1 muscle fiber predominance (HP:0003803) | 3.45158594 |
| 37 | Acute necrotizing encephalopathy (HP:0006965) | 3.41976591 |
| 38 | Muscle stiffness (HP:0003552) | 3.41764141 |
| 39 | Palpitations (HP:0001962) | 3.36486661 |
| 40 | Frequent falls (HP:0002359) | 3.34915487 |
| 41 | Abnormal mitochondria in muscle tissue (HP:0008316) | 3.21664271 |
| 42 | Distal lower limb muscle weakness (HP:0009053) | 3.19440986 |
| 43 | Heart block (HP:0012722) | 3.18143196 |
| 44 | Ventricular arrhythmia (HP:0004308) | 3.15077940 |
| 45 | Malignant hyperthermia (HP:0002047) | 3.03543145 |
| 46 | Abnormal atrioventricular conduction (HP:0005150) | 2.99023709 |
| 47 | Abnormal finger flexion creases (HP:0006143) | 2.88878381 |
| 48 | Progressive macrocephaly (HP:0004481) | 2.85056922 |
| 49 | Mitochondrial inheritance (HP:0001427) | 2.83678059 |
| 50 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.83137294 |
| 51 | Acute encephalopathy (HP:0006846) | 2.79021391 |
| 52 | Left ventricular hypertrophy (HP:0001712) | 2.78354700 |
| 53 | Hepatic necrosis (HP:0002605) | 2.78156044 |
| 54 | Neck muscle weakness (HP:0000467) | 2.76416530 |
| 55 | Areflexia of lower limbs (HP:0002522) | 2.75556570 |
| 56 | Myopathic facies (HP:0002058) | 2.67908703 |
| 57 | Abnormal EKG (HP:0003115) | 2.60931970 |
| 58 | Hepatocellular necrosis (HP:0001404) | 2.59264750 |
| 59 | Atrioventricular block (HP:0001678) | 2.57266937 |
| 60 | Distal arthrogryposis (HP:0005684) | 2.56587834 |
| 61 | Ventricular fibrillation (HP:0001663) | 2.55916051 |
| 62 | Bulbar palsy (HP:0001283) | 2.55540913 |
| 63 | Difficulty climbing stairs (HP:0003551) | 2.53160088 |
| 64 | Rimmed vacuoles (HP:0003805) | 2.50972208 |
| 65 | Round ear (HP:0100830) | 2.50484829 |
| 66 | Increased variability in muscle fiber diameter (HP:0003557) | 2.49019671 |
| 67 | Progressive muscle weakness (HP:0003323) | 2.47460886 |
| 68 | Increased CSF lactate (HP:0002490) | 2.47083839 |
| 69 | Exercise intolerance (HP:0003546) | 2.46226059 |
| 70 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.45552971 |
| 71 | Weak cry (HP:0001612) | 2.41957808 |
| 72 | Fetal akinesia sequence (HP:0001989) | 2.39195980 |
| 73 | Increased muscle lipid content (HP:0009058) | 2.37801949 |
| 74 | Distal lower limb amyotrophy (HP:0008944) | 2.31657273 |
| 75 | Increased intramyocellular lipid droplets (HP:0012240) | 2.31492247 |
| 76 | Slender build (HP:0001533) | 2.31129431 |
| 77 | Ragged-red muscle fibers (HP:0003200) | 2.28995298 |
| 78 | Abnormality of the calcaneus (HP:0008364) | 2.28617625 |
| 79 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.26022527 |
| 80 | Abnormality of alanine metabolism (HP:0010916) | 2.26022527 |
| 81 | Hyperalaninemia (HP:0003348) | 2.26022527 |
| 82 | Gowers sign (HP:0003391) | 2.24797380 |
| 83 | Ketoacidosis (HP:0001993) | 2.24094100 |
| 84 | Large for gestational age (HP:0001520) | 2.21885925 |
| 85 | Muscular dystrophy (HP:0003560) | 2.18942820 |
| 86 | Cerebral edema (HP:0002181) | 2.17196568 |
| 87 | Palmoplantar keratoderma (HP:0000982) | 2.16288019 |
| 88 | Hyperkalemia (HP:0002153) | 2.16041574 |
| 89 | Fatigable weakness (HP:0003473) | 2.15683780 |
| 90 | Abnormality of the neuromuscular junction (HP:0003398) | 2.15683780 |
| 91 | Lipid accumulation in hepatocytes (HP:0006561) | 2.15110334 |
| 92 | Hip contracture (HP:0003273) | 2.13668794 |
| 93 | Spinal rigidity (HP:0003306) | 2.09827216 |
| 94 | Proximal amyotrophy (HP:0007126) | 2.08125762 |
| 95 | Increased hepatocellular lipid droplets (HP:0006565) | 2.04834521 |
| 96 | Hypoplastic ischia (HP:0003175) | 2.02684519 |
| 97 | Lactic acidosis (HP:0003128) | 2.02592480 |
| 98 | Testicular atrophy (HP:0000029) | 2.00279964 |
| 99 | Optic disc pallor (HP:0000543) | 1.99695230 |
| 100 | Waddling gait (HP:0002515) | 1.98835913 |
| 101 | Abnormality of the shoulder girdle musculature (HP:0001435) | 1.97771600 |
| 102 | Respiratory failure (HP:0002878) | 1.95922668 |
| 103 | Foot dorsiflexor weakness (HP:0009027) | 1.95272687 |
| 104 | Abnormality of the foot musculature (HP:0001436) | 1.93977224 |
| 105 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 1.91168806 |
| 106 | Renal cortical cysts (HP:0000803) | 1.86126437 |
| 107 | Generalized muscle weakness (HP:0003324) | 1.84651668 |
| 108 | Maternal diabetes (HP:0009800) | 1.84296910 |
| 109 | Limb-girdle muscle atrophy (HP:0003797) | 1.83406625 |
| 110 | Dicarboxylic aciduria (HP:0003215) | 1.81645166 |
| 111 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.81645166 |
| 112 | Scapular winging (HP:0003691) | 1.81149629 |
| 113 | Respiratory insufficiency due to muscle weakness (HP:0002747) | 1.80136927 |
| 114 | Lower limb amyotrophy (HP:0007210) | 1.77797142 |
| 115 | Facial diplegia (HP:0001349) | 1.76949216 |
| 116 | Absent phalangeal crease (HP:0006109) | 1.72331102 |
| 117 | Abnormality of the ischium (HP:0003174) | 1.70063934 |
| 118 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.69593507 |
| 119 | EMG: neuropathic changes (HP:0003445) | 1.69186716 |
| 120 | Limb-girdle muscle weakness (HP:0003325) | 1.67872715 |
| 121 | Renal Fanconi syndrome (HP:0001994) | 1.67288414 |
| 122 | Abnormality of the musculature of the pelvis (HP:0001469) | 1.64828130 |
| 123 | Abnormality of the hip-girdle musculature (HP:0001445) | 1.64828130 |
| 124 | Methylmalonic acidemia (HP:0002912) | 1.64173853 |
| 125 | Congenital malformation of the right heart (HP:0011723) | 1.63125498 |
| 126 | Double outlet right ventricle (HP:0001719) | 1.63125498 |
| 127 | Metatarsus adductus (HP:0001840) | 1.61982988 |
| 128 | Pelvic girdle muscle weakness (HP:0003749) | 1.56290553 |
| 129 | Shoulder girdle muscle weakness (HP:0003547) | 1.56146569 |
| 130 | Paralysis (HP:0003470) | 1.52745262 |
| 131 | Popliteal pterygium (HP:0009756) | 1.52729099 |
| 132 | Nonprogressive disorder (HP:0003680) | 1.50104877 |
| 133 | Long clavicles (HP:0000890) | 1.47680832 |
| 134 | Steppage gait (HP:0003376) | 1.45088065 |
| 135 | Ulnar deviation of finger (HP:0009465) | 1.44170770 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TTN | 5.71252460 |
| 2 | OBSCN | 5.28314904 |
| 3 | PHKG1 | 5.01419076 |
| 4 | PHKG2 | 5.01419076 |
| 5 | DMPK | 2.83703507 |
| 6 | MUSK | 2.67380656 |
| 7 | LMTK2 | 2.59031251 |
| 8 | PINK1 | 2.47701227 |
| 9 | PDK3 | 2.34783184 |
| 10 | PDK4 | 2.34783184 |
| 11 | PIK3CA | 2.31667152 |
| 12 | MYLK | 2.28753641 |
| 13 | GRK7 | 2.24255259 |
| 14 | PKN1 | 1.81665513 |
| 15 | TIE1 | 1.80591706 |
| 16 | NME1 | 1.75965939 |
| 17 | ZAK | 1.71577047 |
| 18 | STK39 | 1.51644323 |
| 19 | BCKDK | 1.50276416 |
| 20 | PDK2 | 1.43181153 |
| 21 | INSRR | 1.40633937 |
| 22 | MAPKAPK3 | 1.34498187 |
| 23 | CAMK2D | 1.30299489 |
| 24 | TNIK | 1.27190895 |
| 25 | EEF2K | 1.25944222 |
| 26 | WNK4 | 1.22679566 |
| 27 | MAP3K7 | 1.22540436 |
| 28 | STK24 | 1.17154574 |
| 29 | CASK | 1.14683276 |
| 30 | PAK3 | 1.07391820 |
| 31 | PRKD1 | 1.04762104 |
| 32 | IRAK3 | 1.02327206 |
| 33 | MAPK12 | 1.02166182 |
| 34 | PIK3CG | 1.00901744 |
| 35 | PRKAA2 | 0.98974761 |
| 36 | EPHB1 | 0.96940948 |
| 37 | TRPM7 | 0.88177104 |
| 38 | LIMK1 | 0.86262354 |
| 39 | CCNB1 | 0.86062805 |
| 40 | ROCK1 | 0.84635439 |
| 41 | PRKAA1 | 0.83262978 |
| 42 | IRAK2 | 0.82929635 |
| 43 | TRIB3 | 0.80538845 |
| 44 | MOS | 0.80509029 |
| 45 | WNK1 | 0.78791301 |
| 46 | CAMK2A | 0.78401505 |
| 47 | DYRK1B | 0.75794328 |
| 48 | STK16 | 0.74353632 |
| 49 | MAPK7 | 0.73979019 |
| 50 | PRKCE | 0.72357362 |
| 51 | MAP3K10 | 0.72339247 |
| 52 | ROCK2 | 0.69520405 |
| 53 | MAP2K3 | 0.69297034 |
| 54 | RIPK1 | 0.66625589 |
| 55 | MAP3K13 | 0.65094968 |
| 56 | CDC42BPA | 0.65050553 |
| 57 | CAMK2G | 0.63469334 |
| 58 | PRPF4B | 0.61386465 |
| 59 | STK38L | 0.60466184 |
| 60 | NEK1 | 0.58849382 |
| 61 | ERBB3 | 0.58590278 |
| 62 | ICK | 0.58561768 |
| 63 | IRAK1 | 0.58508039 |
| 64 | MAPK11 | 0.57284831 |
| 65 | MAPK4 | 0.57176511 |
| 66 | PRKACA | 0.56653796 |
| 67 | KSR2 | 0.56231989 |
| 68 | STK4 | 0.55288313 |
| 69 | PRKACB | 0.52573672 |
| 70 | EPHB2 | 0.52492241 |
| 71 | MARK1 | 0.48084218 |
| 72 | CAMK4 | 0.47781796 |
| 73 | PRKG1 | 0.47655061 |
| 74 | IRAK4 | 0.47055314 |
| 75 | MAP2K1 | 0.46294932 |
| 76 | EPHA3 | 0.45999989 |
| 77 | CAMK1 | 0.45064748 |
| 78 | NEK6 | 0.42830896 |
| 79 | SGK3 | 0.42130869 |
| 80 | TNK2 | 0.41486703 |
| 81 | GRK1 | 0.41299367 |
| 82 | CAMK2B | 0.40721075 |
| 83 | EIF2AK2 | 0.39331632 |
| 84 | SGK1 | 0.39190857 |
| 85 | AKT2 | 0.38726273 |
| 86 | ILK | 0.36262091 |
| 87 | RPS6KL1 | 0.35870306 |
| 88 | RPS6KC1 | 0.35870306 |
| 89 | TGFBR2 | 0.34666639 |
| 90 | MAP2K6 | 0.33764193 |
| 91 | PRKCQ | 0.33161696 |
| 92 | ADRBK1 | 0.33124994 |
| 93 | TBK1 | 0.32074977 |
| 94 | MAPK15 | 0.31899254 |
| 95 | MAPK13 | 0.31236937 |
| 96 | PRKACG | 0.31051187 |
| 97 | ADRBK2 | 0.30907833 |
| 98 | MAP3K5 | 0.30697282 |
| 99 | NEK9 | 0.30318282 |
| 100 | BLK | 0.30083742 |
| 101 | ARAF | 0.29251617 |
| 102 | RPS6KA6 | 0.28848322 |
| 103 | TAOK2 | 0.28666030 |
| 104 | UHMK1 | 0.28304396 |
| 105 | SGK2 | 0.28052652 |
| 106 | NUAK1 | 0.27550880 |
| 107 | NME2 | 0.27314335 |
| 108 | SIK1 | 0.27296690 |
| 109 | LATS2 | 0.27020428 |
| 110 | RPS6KA3 | 0.26720948 |
| 111 | RPS6KA1 | 0.25072984 |
| 112 | RPS6KB2 | 0.24742207 |
| 113 | MAP3K1 | 0.24365137 |
| 114 | BMPR2 | 0.24244726 |
| 115 | MARK2 | 0.24212716 |
| 116 | RPS6KB1 | 0.23615306 |
| 117 | PDPK1 | 0.23407214 |
| 118 | NTRK2 | 0.23368881 |
| 119 | MAPK10 | 0.23285011 |
| 120 | SGK494 | 0.22128812 |
| 121 | SGK223 | 0.22128812 |
| 122 | PKN2 | 0.21423977 |
| 123 | FES | 0.20725162 |
| 124 | OXSR1 | 0.20560176 |
| 125 | CDK3 | 0.20320394 |
| 126 | MAP2K7 | 0.20160723 |
| 127 | MAP2K4 | 0.19503710 |
| 128 | BMPR1B | 0.19360847 |
| 129 | PRKD2 | 0.19317764 |
| 130 | MAP3K6 | 0.18604523 |
| 131 | MTOR | 0.18115320 |
| 132 | BRAF | 0.17816601 |
| 133 | PDK1 | 0.16982084 |
| 134 | DAPK2 | 0.16464410 |
| 135 | RAF1 | 0.16071701 |
| 136 | ERN1 | 0.11132252 |
| 137 | MARK3 | 0.10547720 |
| 138 | MAP3K11 | 0.10249671 |
| 139 | ZAP70 | 0.09822449 |
| 140 | STK11 | 0.07313104 |
| 141 | RPS6KA2 | 0.07068123 |
| 142 | MAPK9 | 0.05924703 |
| 143 | MAP2K2 | 0.04833252 |
| 144 | KSR1 | 0.04483324 |
| 145 | LATS1 | 0.04288066 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 4.76623620 |
| 2 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 4.16288409 |
| 3 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 3.99152281 |
| 4 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 3.89451729 |
| 5 | Parkinsons disease_Homo sapiens_hsa05012 | 3.87881438 |
| 6 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 3.79388676 |
| 7 | Alzheimers disease_Homo sapiens_hsa05010 | 3.13521715 |
| 8 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.96522544 |
| 9 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 2.94398958 |
| 10 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 2.71940731 |
| 11 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.71355511 |
| 12 | Huntingtons disease_Homo sapiens_hsa05016 | 2.48017887 |
| 13 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.36714839 |
| 14 | Fatty acid elongation_Homo sapiens_hsa00062 | 2.09317068 |
| 15 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.04665735 |
| 16 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.83782672 |
| 17 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.82676873 |
| 18 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.70913735 |
| 19 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.69535074 |
| 20 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.68734376 |
| 21 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.63155696 |
| 22 | Viral myocarditis_Homo sapiens_hsa05416 | 1.62716501 |
| 23 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.53907683 |
| 24 | Carbon metabolism_Homo sapiens_hsa01200 | 1.51179241 |
| 25 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.50488137 |
| 26 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.35621985 |
| 27 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.32255070 |
| 28 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.17133645 |
| 29 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.09203117 |
| 30 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.08895245 |
| 31 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.08497181 |
| 32 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.99559126 |
| 33 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.97956080 |
| 34 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.95929758 |
| 35 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.91921335 |
| 36 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.89245694 |
| 37 | Insulin resistance_Homo sapiens_hsa04931 | 0.80550337 |
| 38 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.79043685 |
| 39 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.78493507 |
| 40 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.75378789 |
| 41 | Long-term potentiation_Homo sapiens_hsa04720 | 0.73678320 |
| 42 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.73150190 |
| 43 | Circadian rhythm_Homo sapiens_hsa04710 | 0.72966599 |
| 44 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.72864439 |
| 45 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.72398962 |
| 46 | Renin secretion_Homo sapiens_hsa04924 | 0.68535804 |
| 47 | Taste transduction_Homo sapiens_hsa04742 | 0.68091088 |
| 48 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.65160892 |
| 49 | Lysine degradation_Homo sapiens_hsa00310 | 0.64294960 |
| 50 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.63783357 |
| 51 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.63582959 |
| 52 | Insulin secretion_Homo sapiens_hsa04911 | 0.62664236 |
| 53 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.62271812 |
| 54 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.60943254 |
| 55 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.60060921 |
| 56 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.59548014 |
| 57 | Tight junction_Homo sapiens_hsa04530 | 0.55796139 |
| 58 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.54937569 |
| 59 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.54888788 |
| 60 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.54827752 |
| 61 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.54131665 |
| 62 | Morphine addiction_Homo sapiens_hsa05032 | 0.54071887 |
| 63 | Circadian entrainment_Homo sapiens_hsa04713 | 0.53837441 |
| 64 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.53564722 |
| 65 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.53070084 |
| 66 | Peroxisome_Homo sapiens_hsa04146 | 0.52925525 |
| 67 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.52491316 |
| 68 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.51419095 |
| 69 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.50593223 |
| 70 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.50171803 |
| 71 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.49027648 |
| 72 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.48833635 |
| 73 | Focal adhesion_Homo sapiens_hsa04510 | 0.44635585 |
| 74 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.42835001 |
| 75 | Axon guidance_Homo sapiens_hsa04360 | 0.42027011 |
| 76 | Metabolic pathways_Homo sapiens_hsa01100 | 0.40165407 |
| 77 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.38756901 |
| 78 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.38556564 |
| 79 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.35325456 |
| 80 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.34729138 |
| 81 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.34652887 |
| 82 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.34642224 |
| 83 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.32578417 |
| 84 | GABAergic synapse_Homo sapiens_hsa04727 | 0.31308192 |
| 85 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.31128980 |
| 86 | Nicotine addiction_Homo sapiens_hsa05033 | 0.31028592 |
| 87 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.30031104 |
| 88 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.29055854 |
| 89 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.28881539 |
| 90 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.28875149 |
| 91 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.28653055 |
| 92 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.28623773 |
| 93 | Salivary secretion_Homo sapiens_hsa04970 | 0.28506387 |
| 94 | Phototransduction_Homo sapiens_hsa04744 | 0.25923361 |
| 95 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.25140213 |
| 96 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.24124488 |
| 97 | Platelet activation_Homo sapiens_hsa04611 | 0.23800915 |
| 98 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.23353331 |
| 99 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.23213922 |
| 100 | Glioma_Homo sapiens_hsa05214 | 0.21663811 |
| 101 | ABC transporters_Homo sapiens_hsa02010 | 0.21490196 |
| 102 | Long-term depression_Homo sapiens_hsa04730 | 0.21047358 |
| 103 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.20430345 |
| 104 | Sulfur relay system_Homo sapiens_hsa04122 | 0.19860831 |
| 105 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.19606358 |
| 106 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.17483653 |
| 107 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.17337688 |
| 108 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.17200444 |
| 109 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.16412157 |
| 110 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.15785334 |
| 111 | Purine metabolism_Homo sapiens_hsa00230 | 0.15595768 |
| 112 | Galactose metabolism_Homo sapiens_hsa00052 | 0.15444413 |
| 113 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.15071841 |
| 114 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.14840467 |
| 115 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.14807365 |
| 116 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.13508875 |
| 117 | Gap junction_Homo sapiens_hsa04540 | 0.13444603 |
| 118 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.12079899 |
| 119 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.10278733 |
| 120 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.09666540 |
| 121 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.09550670 |
| 122 | Amoebiasis_Homo sapiens_hsa05146 | 0.08992969 |
| 123 | Bile secretion_Homo sapiens_hsa04976 | 0.08765985 |
| 124 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.07435604 |
| 125 | Endometrial cancer_Homo sapiens_hsa05213 | 0.07288434 |
| 126 | Adherens junction_Homo sapiens_hsa04520 | 0.07070456 |
| 127 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.06404314 |
| 128 | Melanogenesis_Homo sapiens_hsa04916 | 0.05093471 |

